- Investing Ideas
- /
- Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies
Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
75
Companies with a Value score of at least 3, ordered by Value score
75 companies
ACADIA Pharmaceuticals
Market Cap: Mex$4.0b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD *
Mex$400.00
7D
0%
1Y
n/a
Fortrea Holdings
Market Cap: Mex$1.8b
A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
FTRE1 *
Mex$435.30
7D
0%
1Y
n/a
Mirum Pharmaceuticals
Market Cap: Mex$3.7b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM *
Mex$1,256.12
7D
0%
1Y
n/a
BioCryst Pharmaceuticals
Market Cap: Mex$1.5b
A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.
BCRX *
Mex$159.50
7D
0%
1Y
2.9%
Sanofi
Market Cap: Mex$106.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SNY N
Mex$955.00
7D
1.6%
1Y
-9.6%
GSK
Market Cap: Mex$71.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK N
Mex$864.00
7D
-0.2%
1Y
29.9%
Sanofi
Market Cap: Mex$106.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN1 N
Mex$1,884.93
7D
0%
1Y
n/a
United Therapeutics
Market Cap: Mex$20.5b
A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR *
Mex$8,085.00
7D
0%
1Y
n/a
Otsuka Holdings
Market Cap: Mex$4.4t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578 N
Mex$1,025.98
7D
0%
1Y
n/a
WuXi Biologics (Cayman)
Market Cap: Mex$61.6b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269 N
Mex$62.53
7D
0%
1Y
n/a
Agios Pharmaceuticals
Market Cap: Mex$2.0b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO *
Mex$1,222.00
7D
0%
1Y
n/a
PeptiDream
Market Cap: Mex$278.1b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587 N
Mex$378.19
7D
0%
1Y
n/a
Genmab
Market Cap: Mex$120.3b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB N
Mex$5,279.48
7D
0%
1Y
n/a
Hikma Pharmaceuticals
Market Cap: Mex$3.5b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIK N
Mex$432.63
7D
0%
1Y
n/a
Bausch Health Companies
Market Cap: Mex$2.3b
Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.
BHC N
Mex$130.00
7D
0%
1Y
n/a
Takeda Pharmaceutical
Market Cap: Mex$6.9t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
TAK N
Mex$262.60
7D
0%
1Y
n/a
Merck KGaA
Market Cap: Mex$63.7b
Operates as a science and technology company in Germany and internationally.
MRK1 N
Mex$3,299.85
7D
0%
1Y
n/a
Ultragenyx Pharmaceutical
Market Cap: Mex$3.9b
A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.
RARE *
Mex$1,150.56
7D
0%
1Y
n/a
Qiagen
Market Cap: Mex$9.6b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QIA N
Mex$912.70
7D
0%
1Y
8.9%
Novartis
Market Cap: Mex$195.7b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN N
Mex$2,411.45
7D
6.9%
1Y
n/a
BioNTech
Market Cap: Mex$24.7b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
BNTX N
Mex$1,800.00
7D
-5.0%
1Y
-11.3%
argenx
Market Cap: Mex$48.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX N
Mex$15,022.00
7D
0%
1Y
n/a
Gerresheimer
Market Cap: Mex$3.6b
Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI N
Mex$1,649.75
7D
0%
1Y
n/a
Charles River Laboratories International
Market Cap: Mex$9.0b
Charles River Laboratories International, Inc.
CRL *
Mex$4,066.92
7D
0%
1Y
n/a
Insmed
Market Cap: Mex$41.2b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM *
Mex$2,407.92
7D
0%
1Y
n/a
Tempus AI
Market Cap: Mex$11.8b
Operates as a healthcare technology company.
TEM *
Mex$1,247.00
7D
-6.3%
1Y
n/a
Teva Pharmaceutical Industries
Market Cap: Mex$28.2b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA N
Mex$464.40
7D
1.0%
1Y
33.8%
Neurocrine Biosciences
Market Cap: Mex$13.8b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX *
Mex$2,677.50
7D
0%
1Y
n/a
Illumina
Market Cap: Mex$18.6b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN *
Mex$2,182.00
7D
-3.0%
1Y
-29.5%
AbbVie
Market Cap: Mex$413.3b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV *
Mex$4,243.33
7D
-0.7%
1Y
24.7%
Ascendis Pharma
Market Cap: Mex$13.3b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND N
Mex$3,610.00
7D
-1.8%
1Y
n/a
Ono Pharmaceutical
Market Cap: Mex$1.3t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528 N
Mex$341.69
7D
0%
1Y
-34.5%
Haleon
Market Cap: Mex$32.6b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN1 N
Mex$170.00
7D
0%
1Y
n/a
Novartis
Market Cap: Mex$195.7b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS N
Mex$2,419.00
7D
3.5%
1Y
n/a
Daiichi Sankyo Company
Market Cap: Mex$6.8t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568 N
Mex$493.73
7D
0%
1Y
n/a
uniQure
Market Cap: Mex$1.9b
Develops treatments for patients suffering from rare and other devastating diseases in the United States.
QURE N
Mex$1,065.69
7D
0%
1Y
n/a